v3.22.0.1
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)
Jan. 31, 2022
Apr. 30, 2021
Current assets:    
Cash and cash equivalents $ 86,639,757 $ 2,202,106
Prepaid expenses and other current assets 174,101 73,131
Total current assets 86,813,858 2,275,237
Other assets:    
Intangibles 3,549,427 3,549,427
Investment in SG Austria 1,572,193 1,572,193
Other assets 7,688 7,372
Total other assets 5,129,308 5,128,992
Total Assets 91,943,166 7,404,229
Current liabilities:    
Accounts payable 92,861 172,261
Accrued expenses 520,115 552,517
Total current liabilities 612,976 724,778
Total Liabilities 612,976 724,778
Commitments and Contingencies (Notes 7 and 9)
Stockholders' equity:    
Common stock, authorized: 33,333,334 shares, $0.0001 par value; 20,720,204 and 1,590,084 shares issued and outstanding as of January 31, 2022, and April 30, 2021, respectively 2,072 159
Additional paid-in capital 201,573,368 114,109,169
Accumulated deficit (110,225,949) (107,409,495)
Accumulated other comprehensive loss (19,301) (20,382)
Total stockholders' equity 91,330,190 6,679,451
Total Liabilities and Stockholders' Equity $ 91,943,166 $ 7,404,229

Source

v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Jan. 31, 2022
Jan. 31, 2021
Income Statement [Abstract]        
Revenue $ 0 $ 0 $ 0 $ 0
Operating expenses:        
Research and development costs 158,039 174,088 436,872 595,976
Compensation expense 267,110 336,095 801,007 1,167,527
Director fees 84,897 65,953 209,110 207,294
Legal and professional 130,758 95,720 601,388 325,888
General and administrative 215,315 84,991 835,936 291,353
Total operating expenses 856,119 756,847 2,884,313 2,588,038
Loss from operations (856,119) (756,847) (2,884,313) (2,588,038)
Other expenses:        
Interest income 45,459 0 71,078 0
Interest expense 0 (249) (509) (2,006)
Other expense (630) 0 (2,710) (1,188)
Total other income (expenses) 44,829 (249) 67,859 (3,194)
Net loss $ (811,290) $ (757,096) $ (2,816,454) $ (2,591,232)
Basic and diluted loss per share $ (0.04) $ (0.49) $ (0.21) $ (1.84)
Weighted average shares outstanding basic and diluted 21,667,239 1,558,023 13,538,792 1,405,517

Source

v3.22.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
9 Months Ended
Jan. 31, 2022
Jan. 31, 2021
Cash flows from operating activities:    
Net loss $ (2,816,454) $ (2,591,232)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock issued for services 31,773 65,117
Stock issued for compensation 30,396 183,206
Stock-based compensation – options 41,893 166,982
Change in assets and liabilities:    
(Increase) decrease in prepaid expenses and other current assets (100,970) 101,075
Increase in other assets (316) 0
Decrease in accounts payable (79,399) (106,682)
Decrease in accrued expenses (32,402) (209,052)
Net cash used in operating activities (2,925,479) (2,390,586)
Cash flows from investing activities:    
Net cash provided by (used in) investing activities 0 0
Cash flows from financing activities:    
Use of funds for payment of insurance financing loan 0 (113,245)
Proceeds from the issuance of pre-funded warrants 31,669,027 0
Proceeds from sale of common stock, net of issuance costs 55,693,022 4,699,247
Net cash provided by financing activities 87,362,049 4,586,002
Effect of currency rate exchange on cash and cash equivalents 1,081 694
Net increase in cash and equivalents 84,437,651 2,196,110
Cash and cash equivalents at beginning of the periods 2,202,106 894,861
Cash and cash equivalents at end of the periods 86,639,757 3,090,971
Supplemental disclosure of cash flows information:    
Cash paid during the periods for income taxes 1,600 800
Cash paid during the periods for interest expense $ 509 $ 2,006

Source